167 related articles for article (PubMed ID: 28303695)
1. Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases.
Hatzoglou V; Tisnado J; Mehta A; Peck KK; Daras M; Omuro AM; Beal K; Holodny AI
Cancer Med; 2017 Apr; 6(4):761-767. PubMed ID: 28303695
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.
Arevalo-Perez J; Kebede AA; Peck KK; Diamond E; Holodny AI; Rosenblum M; Rubel J; Gaal J; Hatzoglou V
J Neuroimaging; 2016 May; 26(3):366-71. PubMed ID: 26707628
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.
Kuchcinski G; Le Rhun E; Cortot AB; Drumez E; Duhal R; Lalisse M; Dumont J; Lopes R; Pruvo JP; Leclerc X; Delmaire C
Eur Radiol; 2017 Sep; 27(9):3733-3743. PubMed ID: 28210799
[TBL] [Abstract][Full Text] [Related]
4. Association of choline levels and tumor perfusion in brain metastases assessed with proton MR spectroscopy and dynamic susceptibility contrast-enhanced perfusion weighted MRI.
Huang BY; Kwock L; Castillo M; Smith JK
Technol Cancer Res Treat; 2010 Aug; 9(4):327-37. PubMed ID: 20626199
[TBL] [Abstract][Full Text] [Related]
5. Histogram Analysis of ADC Maps for Differentiating Brain Metastases From Different Histological Types of Lung Cancers.
Bozdağ M; Er A; Çinkooğlu A
Can Assoc Radiol J; 2021 May; 72(2):271-278. PubMed ID: 32602365
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRI.
Jung BC; Arevalo-Perez J; Lyo JK; Holodny AI; Karimi S; Young RJ; Peck KK
J Neuroimaging; 2016; 26(2):240-6. PubMed ID: 26235208
[TBL] [Abstract][Full Text] [Related]
7. Correlation Between Tumor Metabolism and Semiquantitative Perfusion Magnetic Resonance Imaging Metrics in Non-Small Cell Lung Cancer.
Lee SH; Rimner A; Gelb E; Deasy JO; Hunt MA; Humm JL; Tyagi N
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):718-726. PubMed ID: 29680254
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of brain metastases from small and non-small lung cancers using apparent diffusion coefficient (ADC) maps.
Müller SJ; Khadhraoui E; Neef NE; Riedel CH; Ernst M
BMC Med Imaging; 2021 Apr; 21(1):70. PubMed ID: 33858368
[TBL] [Abstract][Full Text] [Related]
9. DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife.
Morabito R; Alafaci C; Pergolizzi S; Pontoriero A; Iati' G; Bonanno L; Gaeta M; Salpietro FM; Mormina E; Longo M; Granata F
Radiat Oncol; 2019 Apr; 14(1):65. PubMed ID: 30992043
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of Hemangioblastoma from Metastatic Brain Tumor using Dynamic Contrast-enhanced MR Imaging.
Cha J; Kim ST; Nam DH; Kong DS; Kim HJ; Kim YK; Kim HY; Park GM; Jeon P; Kim KH; Byun HS
Clin Neuroradiol; 2017 Sep; 27(3):329-334. PubMed ID: 26952018
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
12. Dual-input tracer kinetic modeling of dynamic contrast-enhanced MRI in thoracic malignancies.
Lee SH; Rimner A; Deasy JO; Hunt MA; Tyagi N
J Appl Clin Med Phys; 2019 Nov; 20(11):169-188. PubMed ID: 31602789
[TBL] [Abstract][Full Text] [Related]
13. T1-weighted Dynamic Contrast-enhanced MRI to Differentiate Nonneoplastic and Malignant Vertebral Body Lesions in the Spine.
Guan Y; Peck KK; Lyo J; Tisnado J; Lis E; Arevalo-Perez J; Yamada Y; Hameed MR; Karimi S; Holodny A
Radiology; 2020 Nov; 297(2):382-389. PubMed ID: 32870135
[TBL] [Abstract][Full Text] [Related]
14. Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.
Schoenmaekers J; Hofman P; Bootsma G; Westenend M; de Booij M; Schreurs W; Houben R; De Ruysscher D; Dingemans AM; Hendriks LEL
Eur J Cancer; 2019 Jul; 115():88-96. PubMed ID: 31129385
[TBL] [Abstract][Full Text] [Related]
15. Differentiating Small-Cell Lung Cancer From Non-Small-Cell Lung Cancer Brain Metastases Based on MRI Using Efficientnet and Transfer Learning Approach.
Grossman R; Haim O; Abramov S; Shofty B; Artzi M
Technol Cancer Res Treat; 2021; 20():15330338211004919. PubMed ID: 34030542
[TBL] [Abstract][Full Text] [Related]
16. Classifying brain metastases by their primary site of origin using a radiomics approach based on texture analysis: a feasibility study.
Ortiz-Ramón R; Larroza A; Ruiz-España S; Arana E; Moratal D
Eur Radiol; 2018 Nov; 28(11):4514-4523. PubMed ID: 29761357
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance perfusion characteristics of hypervascular renal and hypovascular prostate spinal metastases: clinical utilities and implications.
Saha A; Peck KK; Lis E; Holodny AI; Yamada Y; Karimi S
Spine (Phila Pa 1976); 2014 Nov; 39(24):E1433-40. PubMed ID: 25188594
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.
Hatzoglou V; Oh JH; Buck O; Lin X; Lee M; Shukla-Dave A; Young RJ; Peck KK; Vachha B; Holodny AI; Grommes C
J Neurooncol; 2018 Nov; 140(2):351-358. PubMed ID: 30073640
[TBL] [Abstract][Full Text] [Related]
19. Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status.
Hu Y; Zhang N; Yu MH; Zhou XJ; Ge M; Shen DD; Hua Y; Shi JL; Jia ZZ
Eur J Radiol; 2020 Oct; 131():109247. PubMed ID: 32891974
[TBL] [Abstract][Full Text] [Related]
20. A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.
Hatzoglou V; Yang TJ; Omuro A; Gavrilovic I; Ulaner G; Rubel J; Schneider T; Woo KM; Zhang Z; Peck KK; Beal K; Young RJ
Neuro Oncol; 2016 Jun; 18(6):873-80. PubMed ID: 26688076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
